$84B
$1.97 Million
0.0% of portfolio
34
Q2 2024
Reduced 71.9%
$1.43B
$8.61 Million
0.0% of portfolio
349
Q4 2023
Added 17.11%
$29.2B
$14.8 Million
0.0% of portfolio
134
Q4 2023
Reduced 10.67%
$11.2B
$6.5 Million
0.0% of portfolio
56
Q3 2023
Reduced 95.19%
$71.4B
$14.8 Million
0.0% of portfolio
14
Q3 2023
Added 180.0%
$318M
$8.52 Million
0.0% of portfolio
2,000
Q2 2023
New
$18.1B
$17.6 Million
0.0% of portfolio
400
Q2 2024
Reduced 12.09%
$11.4B
$1.32 Million
0.0% of portfolio
20
Q2 2024
Reduced 96.11%
$1.21B
$894,000
0.0% of portfolio
486
Q3 2023
Reduced 94.72%
$3.49B
$1.07 Million
0.0% of portfolio
15
Q2 2023
New
Oncternal Therapeutics Incorporated Com New
-
$23,000
0.0% of portfolio
-
Q1 2024
New
$39.3B
$17.2 Million
0.0% of portfolio
179
Q2 2024
Reduced 38.49%
$87.7B
$33.1 Million
0.0% of portfolio
191
Q2 2024
Reduced 75.79%
$0
$7.53 Million
0.0% of portfolio
172
Q2 2024
Reduced 84.38%
$0
$32.5 Million
0.0% of portfolio
87
Q2 2023
New
$0
$959,000
0.0% of portfolio
12
Q2 2024
New
$0
$3 Million
0.0% of portfolio
52
Q2 2024
New
$0
$7.22 Million
0.0% of portfolio
159
Q2 2024
New
$0
$9.94 Million
0.0% of portfolio
106
Q2 2024
New
$0
$6.09 Million
0.0% of portfolio
35
Q1 2024
Added 2.94%
$0
$13.8 Million
0.0% of portfolio
191
Q2 2024
Added 85.44%
$0
$8.4 Million
0.0% of portfolio
170
Q2 2024
Reduced 91.47%
$0
$899,000
0.0% of portfolio
9
Q2 2023
New
$1.55B
$2.01 Million
0.0% of portfolio
301
Q2 2023
New
$1.83B
$7,000
0.0% of portfolio
1
Q2 2023
New
$48.6B
$16.2 Million
0.0% of portfolio
25
Q2 2023
New
$2.96B
$731,000
0.0% of portfolio
31
Q3 2023
Reduced 94.92%
$68.4B
$9.09 Million
0.0% of portfolio
229
Q2 2024
Reduced 56.71%
$0
$258,000
0.0% of portfolio
5
Q2 2024
New
$0
$14.6 Million
0.0% of portfolio
56
Q2 2023
New
$0
$4.02 Million
0.0% of portfolio
60
Q2 2023
New
$0
$2.43 Million
0.0% of portfolio
50
Q2 2024
Added 42.86%
$0
$26.2 Million
0.0% of portfolio
434
Q2 2024
Added 449.37%
$5.38B
$16.7 Million
0.0% of portfolio
163
Q2 2024
Added 6.54%
Wk Kellogg Company Com Shs
-
$1.73 Million
0.0% of portfolio
-
Q4 2023
New
$12.5B
$18.2 Million
0.0% of portfolio
331
Q2 2023
New
$34.5B
$12.7 Million
0.0% of portfolio
237
Q1 2024
Added 0.85%
$0
$1.83 Million
0.0% of portfolio
44
Q2 2023
New
$14.1B
$9.74 Million
0.0% of portfolio
316
Q2 2024
Reduced 38.76%
$24B
$2.17 Million
0.0% of portfolio
20
Q3 2023
Reduced 71.43%
$439M
$37,000
0.0% of portfolio
2
Q2 2023
New
$22.3B
$22.7 Million
0.0% of portfolio
800
Q2 2024
Reduced 50.0%
$8.21B
$1.06 Million
0.0% of portfolio
6
Q2 2024
New
$30.5B
$1.65 Million
0.0% of portfolio
9
Q2 2024
Reduced 25.0%
Veralto Corporation Com Shs
-
$477,000
0.0% of portfolio
-
Q4 2023
New
$14.3B
$7.86 Million
0.0% of portfolio
739
Q2 2024
Reduced 1.2%
$29.8B
$6.01 Million
0.0% of portfolio
38
Q3 2023
Reduced 11.63%
$7.48B
$1.81 Million
0.0% of portfolio
150
Q1 2024
Reduced 82.44%
$85.9B
$21.8 Million
0.0% of portfolio
102
Q2 2023
New
$221B
$6.18 Million
0.0% of portfolio
104
Q4 2023
Reduced 95.62%